KMT9-IN-1 (Compound 8) is a KMT9 inhibitor and an ethyl ester prodrug of compound 7b. Inside cells, KMT9-IN-1 releases the active form 7b through the action of esterases. It specifically associates with the KMT9 target within cells, leading to a reduction in H4K12me1 levels. KMT9-IN-1 exhibits antitumor activity against colon cancer and can be employed in research on prostate cancer and hepatocellular carcinoma.
Molecular Weight:
712.25
CAS Number:
[2625406-61-1]
Formula:
C36H47ClFN7O5
Target:
Epigenetic Reader Domain
T211462
* VAT and and shipping costs not included. Errors and price changes excepted
